Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Investment

ImmunoScape takes in $14m sight
UTEC has returned to co-lead a $14m funding round for ImmunoScape, which will use the money to bolster its presence in Singapore and the US.
SambaNova rams through $676m series D
The Stanford-linked artificial intelligence technology developer doubled its valuation to $5.1bn in a round led by SoftBank Vision Fund 2.
Daily deal net: April 14, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aphea.Bio harvests more series B capital
ECBF has supplied an extension to Aphea.Bio’s series B round, which already included Gemma Frisius Fund, Qbic, Vives and V-Bio Ventures.
Vizgen visualises $37m series B
Vizgen co-founder David Walt, a professor at Harvard Medical School, has invested in the spinout as part of its series B round.
HawkEye 360 hooks $55m in series C
Esri helped Allied Minds' satellite constellation operator take its total funding to $155m in a round that will fund the launch of more satellites.
Hack the Box cracks $10.6m round
Osage University Partners was among the investors in the cybersecurity training services provider’s series A round.
Battery Resourcers charges up with $20m
Orbia Ventures led a round for the battery production technology provider that emerged out of Worcester Polytechnic Institute.

Other News

Snorkel AI pipes in $35m
GV returned for a series B round that increased the overall funding for Stanford’s machine learning technology developer to $50m.
Carta Healthcare carves out series A funding
CU Health Innovation Fund has chipped into a $17.3m round for the healthcare data technology provider.
Daily deal net: April 12, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Oxford Endovascular enters series A stage
University of Oxford, OSI and Parkwalk Advisors all returned for Oxford Endovascular’s $10m series A round.
Daily deal net: April 9, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Ventus Therapeutics executes $100m series B
RA Capital has led a $100m series B round for Ventus Therapeutics, which is linked to multiple universities.

Editor's Picks

Investment Unit of the Year: Cambridge Enterprise Seed Funds
With hundreds of university venture funds, internal commercialisation vehicles and third-party firms the reality in today’s innovation ecosystem, selecting the nominees and the winner for Investment Unit of the Year is increasingly challenging.
Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
test reg

Login